Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 376.13M | 297.2M | 245.32M | 205.62M | 198.87M | 212.17M |
Cost of Revenue | 45.5M | 35.4M | 25.21M | 17.56M | 21.14M | 23.54M |
Gross Profit | 330.63M | 261.8M | 220.1M | 188.06M | 177.73M | 188.64M |
Operating Income | 20.88M | -3.67M | -22.29M | 9.86M | 19.01M | 76.26M |
Interest Income | 2.18M | 5.92M | 3.53M | 85K | 59.99K | 713.62K |
Pretax Income | 12.85M | -8.49M | -12.01M | 14.99M | 23.08M | 44.09M |
Net Income | 2.85M | -11.84M | -10.55M | 13.67M | 16M | 37.75M |
Selling & General & Admin | 117.44M | 99.22M | 87.5M | 68.85M | n/a | 65M |
Research & Development | 100.37M | 83.15M | 68.91M | 52.53M | 70.37M | 38.52M |
Other Expenses | 91.95M | 83.1M | 85.98M | 56.82M | 88.35M | 8.86M |
Operating Expenses | 309.75M | 265.47M | 242.39M | 178.2M | 158.72M | 112.38M |
Interest Expense | 10.72M | 9.05M | 5.96M | 5.36M | 7M | 10.31M |
Selling & Marketing Expenses | 6.66M | 7.14M | 6.82M | 6.41M | n/a | 51.6M |
Cost & Expenses | 355.25M | 300.87M | 267.61M | 195.76M | 179.86M | 135.92M |
Income Tax Expense | 10.31M | 3.35M | -1.46M | 1.31M | 7.08M | 6.35M |
Shares Outstanding (Basic) | 71.32M | 68.92M | 65.7M | 82.54M | 87.64M | 79.88M |
Shares Outstanding (Diluted) | 71.32M | 68.92M | 65.7M | 84.28M | 87.64M | 80.98M |
EPS (Basic) | 0.04 | -0.18 | -0.14 | 0.17 | 0.23 | 0.47 |
EPS (Diluted) | 0.04 | -0.18 | -0.14 | 0.16 | 0.21 | 0.47 |
EBITDA | 34.78M | 16.32M | 9.88M | 33.53M | 48.78M | 58.35M |
EBIT | 23.57M | 245K | -6.05M | 20.35M | 29.17M | 50.04M |
Depreciation & Amortization | 11.22M | 16.07M | 15.93M | 13.19M | 19.61M | 8.31M |
Add to Watchlist
Select watchlists to add or remove PHAR